ViGeneron GmbH

October 25, 2023
ViGeneron GmbH

Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology

View Article
August 22, 2023
ViGeneron GmbH

ViGeneron announces EMA Approval of Clinical Trial Application for VG901, a gene therapy to treat Retinitis Pigmentosa

View Article
October 11, 2022
ViGeneron GmbH

ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT

View Article
NEWS